OPS-Code
8-530.a:
Nuclear medicine therapy: Therapy with unsealed radionuclides: Intra-arterial therapy with unsealed radionuclides
- 8-530.a0 Intra-arterial receptor-mediated radionuclide therapy with DOTA-conjugated somatostatin analogs
- 8-530.a1 Intra-arterial therapy with other radioactive receptor-targeting drugs
- 8-530.a2 Intra-arterial radionuclide therapy with radioactive antibodies
- 8-530.a3 Intra-arterial therapy with radiolabeled metabolic substances
- 8-530.a4 Intra-arterial radionuclide therapy with other substances
- 8-530.a5 Selective internal radionuclide therapy (SIRT) with Yttrium‑90-labeled microspheres
- 8-530.a6 Selective internal radionuclide therapy (SIRT) with Rhenium‑188-labeled microspheres
- 8-530.a7 Intra-arterial radioembolization with other substances
- 8-530.a8 Selective internal radionuclide therapy (SIRT) with Holmium‑166-labeled microspheres
- 8-530.ax Other
Note
Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).